EBD Group and LSX are joining forces for LSX World Congress USA, BioPharm America will merge with LSX World Congress USA this September, granting you access to a single larger, cohesive event
Through this combination, you will have additional opportunities to find the right partners and investors through one streamlined experience
ChinaBio® Partnering Forum grants the global biopharma community the opportunity to broaden their reach into the China life science market through unmatched cross-border partnerships.
Engage with the largest network of potential partners to accelerate your cross-border strategies and expand your reach into the China market.
Bio Partnering APAC Summit is a high-end strategic summit focusing on the theme of 'cooperation' in biomedicine in the Asia-Pacific region. Since its first opening in Shanghai in 2016, the BIO APAC Summits have witnessed the transformation and innovation of China's biomedical industry. The drastic historical reforms of China's drug regulatory agencies, the internationalization of biomedical companies' innovative research and development, the emergence of blockbuster cases of cross-border transaction cooperation, and the heat wave of the securities capital market swept the entire biomedical industry. A large number of elites returned to China to start businesses, innovative pharmaceutical companies are racing to go public, valuations of new drug R&D service companies continue to rise, the strategic layout of multinational pharmaceutical companies in China has changed drastically, and biopharmaceutical industrial parks have sprung up.
Lingmed team on behalf of Biotechgate cordially invites all life sciences and non-profit organizations to an online partnering event from May 13 – 17, 2024. Meeting requesting system will open soon and we expect to have over 1,500 delegates registered for the event incl. small Biotech and big Pharma companies. Lingmed's Biotechgate clients can participate this online partnering event with VIP complimentary pass. Please reach out to your support team or account managers.
Bio€quity Europe is the industry’s premier international showcase for financial dealmakers and pharmaceutical executives to assess and network with rising biotechs. More than 80 hand-picked companies will present their stories and participate in the thought-leading program. The 2024 agenda will allow for maximum financial networking through both ample breaks, receptions, and 1x1 meetings using EBD Group’s partneringONE® conference networking solution. Don’t miss this opportunity to potentially find your next blockbuster investment or partnership opportunity.
Asia Bio Partnering Forum is your gateway to Asia’s emerging innovation. Asia Bio Partnering Forum will continue to build on its strong start and will gather biotech and pharma leaders from around the world with hundreds of emerging innovators across Asia Pacific to advance dealmaking in Asia.
BIO-Europe Spring® is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups.
In 2024, BioCentury and BayHelix bring the 3rd East-West Biopharma Summit to Singapore, where 20 years of government-led investment in science, talent and infrastructure has set the stage for the life sciences industry to carry the ball forward. For three decades BioCentury has helped biotech executives and investors make business critical decisions and build larger networks with peers across the innovation ecosystem.
Presenting at Biotech Showcase allows companies to build their profile with investors and strategic partners. In addition, presenters can conduct one-to-one meetings and participate in informal networking. Hear the latest industry trends in workshops and panels featuring key biotech leaders, investors, pharma executives, and other industry advisors.
The Asia Pharma Manufacturing Congress 2023 is one of the high-level strategic summits in the pharmaceutical industry in Asia. The top four global pharmaceutical markets are the United States, China, five European countries and Japan. Asia has an important status in the global pharmaceutical market and is growing rapidly. In recent years, the Chinese state has frequently issued policies on the pharmaceutical industry, vigorously reformed and pushed the policies into practice.
CHINATRIALS 15: Clinical Development Leaders’ Summit returns to Shanghai on November 8-10, 2023 and will again provide the year’s best opportunity to share China clinical development strategies. Last year, CHINATRIALS and PharmaDJ joined forces to co-organize the event and it resulted in record attendance of over 500 attendees and extremely positive feedback from throughout the industry. We are pleased to partner again to co-organize this year’s CHINATRIALS. A lot has happened since last year’s meeting as a number of headwinds have brought in a much more challenging environment for the industry. Join us November 8-10 in Shanghai as China’s clinical development leaders gather for deep and candid discussions on the most-pressing clinical development challenges!
The annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,350 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.
For our 10th Anniversary, we return to Shanghai to re-engage in cross-border collaboration and discussion for:
1) Two days of strategic panels tailored to help busy executives understand emerging opportunities and challenges in China
2)50+ Road Show presentations from China, Asia and Western biotechs selected by BioCentury
3)Four days of C-level partnering: Two days in Shanghai + two days virtual
4)Hybrid event: Attend in-person or virtually via the China Summit digital platform
1) Two days of strategic panels tailored to help busy executives understand emerging opportunities and challenges in China
2)50+ Road Show presentations from China, Asia and Western biotechs selected by BioCentury
3)Four days of C-level partnering: Two days in Shanghai + two days virtual
4)Hybrid event: Attend in-person or virtually via the China Summit digital platform
For a decade, BioCentury and BayHelix and our partners have brought together a global community of C-suite executives and investors focused on biopharma innovation and cross-border collaboration. But the world has changed: Emerging biopharmas in the U.S., Europe and Asia now face the same dilemma: How do you globalize to deliver innovation to patients and achieve an ROI for investors?
Engage with the largest network of potential partners to accelerate your cross-border strategies and expand your reach into the China market. ChinaBio® Partnering Forum returns to Shanghai! 2 days in-person, 2 days virtually. This year's hybrid event enables you to identify, meet and network with leaders across the life science value chain. Access to partneringONE is restricted to registered attendees.ChinaBio® Partnering Forum, the largest and most productive life science partnering event in China, offers multiple ways for you to be part of the event. Explore the options below to learn more about how you can get involved.
The 12th Pharma - Biotech Product and Company Valuation
September 19, 2023 JW Marriot at people’s square Shanghai China
LINGMED LIMITED SHANGHAI together with Venture Valuation is pleased to invite you to a workshop on pharma – biotech Product and Company Valuation [more]
. Understand the valuation concepts and techniques that are commonly
applied in the pharma and biotech world
. Know how to assess and calculate the value of a biotech company
. Learn how to calculate the value of a pharmaceutical in development
and how to structure a licensing deal
. Understand the valuation concepts and techniques that are commonly
applied in the pharma and biotech world
. Know how to assess and calculate the value of a biotech company
. Learn how to calculate the value of a pharmaceutical in development
and how to structure a licensing deal
BioPharm America™ is where biotech industry partnerships get started. This conference provides a proven and highly productive format for establishing new business relationships. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, the world's leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group's acclaimed European events BIO-Europe® and BIO-Europe Spring®
Asia Pharma R&D Leaders 2023
August 24–25, 2023, Shanghai, China
The 12th Asia Pharma R&D Leaders (APRL) is a high-end strategic summit in Asia focusing on drug discovery and development. The 12th APRL 2023 will once again bring together top experts in new drug R&D from global multinational pharmaceutical companies, domestic and international biotechnology companies, scientific research institutes and other institutions.
Asia’s largest bioindustry-focused gathering, BIO Asia–Taiwan 2023, will be held July 26th to 30th, 2023, in Taipei, Taiwan. Co-organized by BIO (US-based global Biotechnology Innovation Organization) and Taiwan BIO (Taiwan Bio Industry Organization), executives, researchers and investors from North America, Europe, and Asia will come together to explore opportunities within Asia's thriving biotech sector. This year’s theme, Embracing Asian Dynamics, highlights Asian’s fast-moving economies and dynamic biomedical ecosystems, and its globally-connected production and value chains. Expect a full schedule of events including an international conference, exhibition, seminars and workshops, company presentations, one-on-one partnering, and our annual industry award ceremony.
euroPLX 82 Noordwijk
June 12–13, 2023, Noordwijk,Netherlands
1 week before and 2 weeks after the event, Delivered Digitally
1 week before and 2 weeks after the event, Delivered Digitally
This 82nd Marketplace is an exchange for licenses, products, assets, distribution deals and other Pharma Business Opportunities ranging from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices.
International Vaccine & Biotech 4.0 Forum (IVB4.0) is a merger of China International Vaccine Innovation Summit (HVIS) and China International Biopharma 4.0 Summit (CIBP4.0). Among them, HVIS has already become the largest and most influential vaccine industry segmentation summit in China after only two sessions, and CIBP4.0 has gained an excellent user reputation at the third CIBP4.0 Summit in 2021 after three years of cultivation.
The BIO International Convention attracts 14,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. Innovative programming around the current and future state of biotech. Including areas like therapeutic frontiers, the business of biotech, regulatory and policy outlooks, and human capital.
Bio€quity Europe is the industry’s premier international showcase for financial dealmakers and pharmaceutical executives to assess and network with rising biotechs. More than 80 hand-picked companies will present their stories and participate in the thought-leading program. The 2023 agenda will allow for maximum financial networking through both ample breaks, receptions, and 1x1 meetings using EBD Group’s partneringONE® conference networking solution. Don’t miss this opportunity to potentially find your next blockbuster investment or partnership opportunity.
Lingmed team on behalf of Biotechgate cordially invites all life sciences and non-profit organizations to an online partnering event from May 8-12, 2023. Meeting requesting system will open soon and we expect to have over 1,500 delegates registered for the event incl. small Biotech and big Pharma companies. Lingmed's Biotechgate clients can participate this online partnering event with VIP complimentary pass. Please reach out to your support team or account managers.
Building on the success of its sister event—ChinaBio® Partnering Forum—Asia Bio Partnering Forum will bring together hundreds of innovators from key Asian markets with life science leaders from around the world to advance dealmaking across Asia. Spark the connections that will help you establish partnerships with key leaders across the life science value chain.
BIO-Europe Spring® is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups.
Lingmed team on behalf of Biotechgate cordially invites all life sciences and non-profit organizations to an online partnering event from Feb 6 - 10, 2023. Meeting requesting system will open soon and we expect to have over 1,500 delegates registered for the event incl. small Biotech and big Pharma companies. Lingmed's Biotechgate clients can participate this online partnering event with VIP complimentary pass. Please reach out to your support team or account managers.
asiaPLX 1 Singapore
February 6–7, 2023, Singapore
1 week before and 2 weeks after the event, Delivered Digitally
1 week before and 2 weeks after the event, Delivered Digitally
This 1st asiaPLX Marketplace is an exchange for licenses, products, assets, distribution deals and other Pharma Business Opportunities ranging from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices. Flexible Partnering: Have an unlimited number of meetings with partners of your choice, either in-person at the venue or virtual during the video days before and after the event. Or arrange a face-to-face meeting plus an unlimited number of one-hour video meetings with the same person or company. Or reschedule a fixed event meeting to a video meeting anytime during the video days before and after the event should you be unable to attend.
Biotech Showcase will give you the opportunity to connect with your peers in-person in San Francisco this January. Not ready to travel? Take advantage of our Digital Pass to still be part of the busiest week in healthcare.This event gives you the opportunity to find thousands of investment opportunities. Participating companies are ranging from early, mid to later stage. From Startup, over Biotech and large Pharma.Showcase your innovations to the Biotech Showcase audience. You may also present as part of one of our specialty tracks, Asia Pacific Showcase, Digital Medicine & Medtech Showcase and Seed Showcase.
Bio Partnering APAC Summit is a high-end strategic summit focusing on the theme of 'cooperation' in biomedicine in the Asia-Pacific region. Since its first opening in Shanghai in 2016, the BIO APAC Summits have witnessed the transformation and innovation of China's biomedical industry. The drastic historical reforms of China's drug regulatory agencies, the internationalization of biomedical companies' innovative research and development, the emergence of blockbuster cases of cross-border transaction cooperation, and the heat wave of the securities capital market swept the entire biomedical industry. A large number of elites returned to China to start businesses, innovative pharmaceutical companies are racing to go public, valuations of new drug R&D service companies continue to rise, the strategic layout of multinational pharmaceutical companies in China has changed drastically, and biopharmaceutical industrial parks have sprung up.
The Asia Pharma Manufacturing Congress 2022 is one of the high-level strategic summits in the pharmaceutical industry in Asia. The top four global pharmaceutical markets are the United States, China, five European countries and Japan. Asia has an important status in the global pharmaceutical market and is growing rapidly. In recent years, the Chinese state has frequently issued policies on the pharmaceutical industry, vigorously reformed and pushed the policies into practice.
BioCentury-BayHelix East-West BioPharma Summit
November 14-16, 2022,San Francisco, USA
November 17-18, 2022, Delivered Digitally
November 17-18, 2022, Delivered Digitally
BioCentury and BayHelix invite you to join the East-West BioPharma Summit (Nov. 14-16, 2022, SF Bay Area). This VIP event incorporates the 9th BioCentury-BayHelix China Healthcare Summit. Along with two additional bonus days of virtual 1x1 meetings Nov. 17 & 18, 2022.For almost a decade, BioCentury and BayHelix and our partners have brought together a global community of C-suite executives and investors focused on the impact of Chinese investment on biopharma innovation. We have benchmarked each step along the way as Chinese entrepreneurs built the “Bridge to Innovation.”
CHINATRIALS 14: Clinical Development Leaders’ Summit returns to Shanghai on November 9-11, 2022 and will again provide the year’s best opportunity to share China clinical development strategies. Last year, CHINATRIALS and PharmaDJ joined forces to co-organize the event and it resulted in record attendance of over 500 attendees and extremely positive feedback from throughout the industry. We are pleased to partner again to co-organize this year’s CHINATRIALS. A lot has happened since last year’s meeting as a number of headwinds have brought in a much more challenging environment for the industry. Join us November 9-11 in Shanghai as China’s clinical development leaders gather for deep and candid discussions on the most-pressing clinical development challenges!
ChinaBio® Partnering Forum returns to Beijing! 2 days in-person, 2 days virtually. Forge cross-border partnerships with leaders from global pharma and biotech companies to innovative startups and researchers from leading universities and institutes, as well as VCs and other investors. ChinaBio® Partnering Forum is a leading biopharma partnering conference where you will gain valuable exposure to the fastest growing healthcare market in the world.
The annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,350 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.
BioPharm America™ is where biotech industry partnerships get started. This conference provides a proven and highly productive format for establishing new business relationships. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, the world's leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group's acclaimed European events BIO-Europe® and BIO-Europe Spring®
Engage with the largest network of potential partners to accelerate your cross-border strategies and expand your reach into the China market. ChinaBio® Partnering Forum returns to Beijing! 2 days in-person, 2 days virtually. This year's hybrid event enables you to identify, meet and network with leaders across the life science value chain. Access to partneringONE is restricted to registered attendees.ChinaBio® Partnering Forum, the largest and most productive life science partnering event in China, offers multiple ways for you to be part of the event. Explore the options below to learn more about how you can get involved.
Lingmed team on behalf of Biotechgate cordially invites all life sciences and non-profit organizations to an online partnering event from Aug 29 to Sep 2 2022. Meeting requesting system will open soon and we expect to have over 1,500 delegates registered for the event incl. small Biotech and big Pharma companies. Lingmed's Biotechgate clients can participate this online partnering event with VIP complimentary pass. Please reach out to your support team or account managers.
LINGMED LIMITED SHANGHAI together with Venture Valuation is pleased to invite you to a workshop on pharma – biotech Product and Company Valuation [more]
. Understand the valuation concepts and techniques that are commonly
applied in the pharma and biotech world
. Know how to assess and calculate the value of a biotech company
. Learn how to calculate the value of a pharmaceutical in development
and how to structure a licensing deal
. Understand the valuation concepts and techniques that are commonly
applied in the pharma and biotech world
. Know how to assess and calculate the value of a biotech company
. Learn how to calculate the value of a pharmaceutical in development
and how to structure a licensing deal
BIO Asia–Taiwan 2022 Onsite + Online is Asia’s premier biomedical industry gathering, including a three-day conference; an international exhibition; BIO’s One-on-One Partnering platform; company presentations; and a program of satellite events. Join us onsite or online - July 27-31, Taipei, Taiwan. www.bioasiataiwan.com
The Asia Pharma Manufacturing Congress 2022 is one of the high-level strategic summits in the pharmaceutical industry in Asia. The top four global pharmaceutical markets are the United States, China, five European countries and Japan. Asia has an important status in the global pharmaceutical market and is growing rapidly. In recent years, the Chinese state has frequently issued policies on the pharmaceutical industry, vigorously reformed and pushed the policies into practice.
The euroPLX 79 Vienna Marketplace for Pharma Business Opportunities is a time-proven window of opportunity for business development and licensing based on the oldest and most often held pharma partnering event worldwide. RauCon's Marketplaces are attended by top pharma business development executives from all over the world.
euroPLX 79 Vienna features a two-days in-person meetings event at the superior four-star Austria Trend Hotel Savoyen in Vienna, Austria, and a digital part before and after for matchmaking, follow-up, and separate video meetings.
Participants control the entire partnering process with one single log-in. Meetings are instantly scheduled. The additional video meetings are held in a secure environment.
euroPLX 79 Vienna features a two-days in-person meetings event at the superior four-star Austria Trend Hotel Savoyen in Vienna, Austria, and a digital part before and after for matchmaking, follow-up, and separate video meetings.
Participants control the entire partnering process with one single log-in. Meetings are instantly scheduled. The additional video meetings are held in a secure environment.
The 11th Asia Pharma R&D Leaders (APRL) is a high-end strategic summit in Asia focusing on drug discovery and development. The 11th APRL 2022 will once again bring together top experts in new drug R&D from global multinational pharmaceutical companies, domestic and international biotechnology companies, scientific research institutes and other institutions.
Bio€quity Europe is the industry’s premier international showcase for financial dealmakers and pharmaceutical executives to assess and network with rising biotechs. More than 80 hand-picked companies will present their stories and participate in the thought-leading program. The 2022 agenda will allow for maximum financial networking through both ample breaks, receptions, and 1x1 meetings using EBD Group’s partneringONE® conference networking solution. Don’t miss this opportunity to potentially find your next blockbuster investment or partnership opportunity.
Lingmed team on behalf of Biotechgate cordially invites all life sciences and non-profit organizations to an online partnering event from May 9-13, 2022. Meeting requesting system will open soon and we expect to have over 1,500 delegates registered for the event incl. small Biotech and big Pharma companies. Lingmed's Biotechgate clients can participate this online partnering event with VIP complimentary pass. Please reach out to your support team or account managers.
BIO-Europe Spring® is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups.
The summit aims to serve as a platform for vertical communication between instrument and equipment makers and vaccine companies to share the latest progress and updates in the industry. Over 300 industry representatives including company executives, industry leaders, renowned experts, government officials from both Chinese and global vaccine industry will be invited to the summit.
The 11th Asia Pharma R&D Leaders (APRL) is a high-end strategic summit in Asia focusing on drug discovery and development. The 11th APRL 2022 will once again bring together top experts in new drug R&D from global multinational pharmaceutical companies, domestic and international biotechnology companies, scientific research institutes and other institutions.
Lingmed team on behalf of Biotechgate cordially invites all life sciences and non-profit organizations to an online partnering event Feb 2022. Meeting requesting system will open soon and we expect to have over 1,500 delegates registered for the event incl. small Biotech and big Pharma companies. Lingmed's Biotechgate clients can participate this online partnering event with VIP complimentary pass. Please reach out to your support team or account managers.
CHINA SHOWCASE ™ provides invaluable opportunities to expand your network with the most influential and experienced leaders in cross-border investment and business development transactions. Don't miss this opportunity to meet with leading industry investors and potential partners from China, US and EU. Through our partnership with EBD Group we are able to offer you this exclusive discount.
Presenting at Biotech Showcase allows companies to build their profile with investors and strategic partners. In addition, presenters can conduct one-to-one meetings and participate in informal networking. Hear the latest industry trends in workshops and panels featuring key biotech leaders, investors, pharma executives, and other industry advisors.
Lingmed team on behalf of Biotechgate cordially invites all life sciences and non-profit organizations to an online partnering event November 2021. Meeting requesting system will open soon and we expect to have over 1,500 delegates registered for the event incl. small Biotech and big Pharma companies. Lingmed's Biotechgate clients can participate this online partnering event with VIP complimentary pass. Please reach out to your support team or account managers.
euroPLX 77 Brussels
November 22-23, 2021, Brussels, Belgium
Video Meetings two weeks before and two weeks after
8 - 21 November 2021 / 24 - 7 December 2021
Video Meetings two weeks before and two weeks after
8 - 21 November 2021 / 24 - 7 December 2021
Based on a 26 years old successful partnering concept, the new Marketplace for Pharma Business Opportunities is a focal point for business offers from all over the world. It features a two-days in-person meetings event embedded in a video meetings period of two weeks before and two weeks after the event. The new single log-in, user account based system lets users conveniently make their own hours to fit their own and their counterparts plans. Video meetings are instantly scheduled and held in a secure environment. Time zone differences are considered automatically. Upon request, users are alerted by SMS of upcoming meetings, to mention a few of the online communication system’s new and practical features.
The on-site event of euroPLX 77 Brussels will be limited to a maximum of 200 attendees. Video attendance is not limited.
The on-site event of euroPLX 77 Brussels will be limited to a maximum of 200 attendees. Video attendance is not limited.
For seven years, the China Healthcare Summit has been building the "Bridge to Innovation" in China. Now, armed with unprecedented funds, Chinese biotechs and medtechs are racing across the Bridge to Innovation. The 8th BioCentury-BayHelix China Healthcare Summit is a propitious time to show how the China story promises to have a lasting impact on the global biopharma industry.
The long-running CHINATRIALS Summit has established itself as the must-attend industry-focused event for global clinical development leaders in China. We are excited to announce the 2021 meeting is co-organized with PharmaDJ, a leading media firm with deep connections to China’s innovative biopharma industry. The partnership enables an in-depth event that covers the latest thinking on the key strategies needed to succeed in clinical development both in China and globally.
Bio Partnering APAC Summit is a high-end strategic summit focusing on the theme of 'cooperation' in biomedicine in the Asia-Pacific region. Since its first opening in Shanghai in 2016, the BIO APAC Summits have witnessed the transformation and innovation of China's biomedical industry. The drastic historical reforms of China's drug regulatory agencies, the internationalization of biomedical companies' innovative research and development, the emergence of blockbuster cases of cross-border transaction cooperation, and the heat wave of the securities capital market swept the entire biomedical industry. A large number of elites returned to China to start businesses, innovative pharmaceutical companies are racing to go public, valuations of new drug R&D service companies continue to rise, the strategic layout of multinational pharmaceutical companies in China has changed drastically, and biopharmaceutical industrial parks have sprung up.
The annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,350 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.
The 16th BD Forum will be held in Suzhou on September 23-24. The forum aims to explore how pharmaceutical and medical companies can expand their business and investment opportunities in the face of global changes, promote rapid growth in integration, and achieve “embrace globally and achieve value”
BioPharm America™ is where biotech industry partnerships get started. This conference provides a proven and highly productive format for establishing new business relationships. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, the world's leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group's acclaimed European events BIO-Europe® and BIO-Europe Spring®
Lingmed team on behalf of Biotechgate cordially invites all life sciences and non-profit organizations to an online partnering event May 2021. Meeting requesting system will open soon and we expect to have over 1,500 delegates registered for the event incl. small Biotech and big Pharma companies. Lingmed's Biotechgate clients can participate this online partnering event with VIP complimentary pass. Please reach out to your support team or account managers.
The 10th Pharma - Biotech Product and Company Valuation
Aug 12-13, 2021, Shanghai Marriot hotel & Zoom rooms
LINGMED LIMITED SHANGHAI together with Venture Valuation is pleased to invite you to workshop on pharma – biotech Product and Company Valuation
1) Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world
2) Know how to assess and calculate the value of a biotech company
3) Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal
1) Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world
2) Know how to assess and calculate the value of a biotech company
3) Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal
The Largest Biotech Business Event in Asia!
Jointly organized by both the Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO). This year's event will be a unique blend of Online and Live gatherings, held on July 21-25 in Taipei, Taiwan with sessions streaming online. This event brings together biopharma executives and investors from Asia, North America, and Europe to meet and explore business opportunities with Taiwan’s emerging biotech sector in both Online and live settings. The five-day event will feature online company presentations, BIO One-on-One Partnering™, online seminars and workshops, and an online exhibition. It is a rare opportunity to reach out to Asia and Global Partners during the Pandemic! Conference agenda is now available at bioasiataiwan.com
The 2021 Asian Pharma Manufacturing Congress will focus on the new trends, new changes and new needs of the pharmaceutical industry under the drug reform. It will bring together pharmaceutical industry regulatory leaders, pharmaceutical industry association leaders, top 100 pharmaceutical companies, multinational pharmaceutical companies, innovative pharmaceutical companies, and pharmaceutical R&D services Leaders and decision makers of enterprises, pharmaceutical industry parks and other institutions will discuss the development of the pharmaceutical industry and promote.
euroPLX 76 Noordwijk
June 14-15, 2021, Noordwijk, Netherlands
Video Meetings two weeks before and two weeks after
31 May - 13 June 2021 / 16 - 29 June 2021
Video Meetings two weeks before and two weeks after
31 May - 13 June 2021 / 16 - 29 June 2021
Based on a 26 years old successful partnering concept, the new Marketplace for Pharma Business Opportunities is a focal point for business offers from all over the world. It features a two-days in-person meetings event embedded in a video meetings period of two weeks before and two weeks after the event. The new single log-in, user account based system lets users conveniently make their own hours to fit their own and their counterparts plans. Video meetings are instantly scheduled and held in a secure environment. Time zone differences are considered automatically. Upon request, users are alerted by SMS of upcoming meetings, to mention a few of the online communication system’s new and practical features.
The on-site event of euroPLX 76 Noordwijk is currently limited to 180 attendees, owing to corona precautions. Video attendance is not limited.
The on-site event of euroPLX 76 Noordwijk is currently limited to 180 attendees, owing to corona precautions. Video attendance is not limited.
Bio€quity Europe is the industry’s premier international showcase for financial dealmakers and pharmaceutical executives to assess and network with rising biotechs. For our 21st anniversary meeting, more than 80 hand-picked companies will present their stories and participate in the thought-leading program. The 2021 agenda will allow for maximum financial networking through both ample breaks, receptions, and 1x1 meetings using EBD Group’s partneringONE® conference networking solution. Don’t miss this opportunity to potentially find your next blockbuster investment or partnership opportunity.
ChinaBio® Partnering Forum 2021, in its new hybrid delivery, will kick off with two days of productive in-person one-to-one meetings in Shanghai, China followed by three days of effortless virtual one-to-one meetings. 2 DAYS IN-PERSON. 3 DAYS VIRTUALLY. ChinaBio® Partnering Forum has grown to be the premier life science partnering conference in China since 2009. ChinaBio® Partnering Forum Digital will be so much more than scheduled virtual partnering meetings, recorded content, some live sessions and networking opportunities during the week of May 10-14. Company pitches and program sessions, as well as enhanced Sponsor and Showcase Company content will be available to complement your partnering preparations. Tune in no matter where you are based and engage with content without interrupting your busy partnering schedule during the main event week.
The China Healthcare Investment Conference (CHIC) is the premier event of its kind, bringing together global and local healthcare investors with the most promising and successful China life science entrepreneurs. Now in our 12th year, CHIC 2021 will be held from March 23-25th, and will mark our first ever hybrid event, with both in-person sessions at the Shanghai Pudong Ritz Carlton and live on-line sessions with a global audience. Valuable 1:1 Meetings will be available online for all attendees. CHIC 2021 will also mark an exciting new partnership with Endpoints News, a global leader in reporting and analyzing the top global biotech and pharmaceutical R&D news of the day. Please save the date in your calendars, and we look forward to seeing you in Shanghai and/or online at CHIC 2021!
The fifteenth annual BIO-Europe Spring® premier springtime partnering conference will be held March 22-25 in a fully digital format. It will include on-demand early access to the company pitches, program sessions, and sponsor and showcase company content up to five weeks prior to the live event for the best possible networking and meeting decisions once partnering begins.
BIO-Europe Spring Digital 2021 is expected to bring together over 2,500 executives from biotechnology, pharmaceutical and finance companies from around the world, who will engage in more than 15,000 partnering meetings. Our gold standard partneringONE® platform is also now more powerful than ever before. With ONE login, you access the entire event. No need to switch back and forth between platforms. Search by company or therapeutic area to discover potential partners and relevant conference sessions and company presentations.
Scheduled meetings will take place during the live conference with unique links to a secure video conferencing solution. Meeting times are extended to be on a 24-hour basis to allow participants to meet conveniently from any time zone.
BIO-Europe Spring Digital 2021 is expected to bring together over 2,500 executives from biotechnology, pharmaceutical and finance companies from around the world, who will engage in more than 15,000 partnering meetings. Our gold standard partneringONE® platform is also now more powerful than ever before. With ONE login, you access the entire event. No need to switch back and forth between platforms. Search by company or therapeutic area to discover potential partners and relevant conference sessions and company presentations.
Scheduled meetings will take place during the live conference with unique links to a secure video conferencing solution. Meeting times are extended to be on a 24-hour basis to allow participants to meet conveniently from any time zone.
The summit aims to serve as a platform for vertical communication between instrument and equipment makers and vaccine companies to share the latest progress and updates in the industry. Over 300 industry representatives including company executives, industry leaders, renowned experts, government officials from both Chinese and global vaccine industry will be invited to the summit.
Based on a 26 years old successful partnering concept, the new Marketplace for Pharma Business Opportunities is a focal point for business offers from all over the world.
Owing to CoViD-19 conditions in Portugal, this Marketplace will be open for pre-arranged virtual (video) business meetings from 1st through 30th of March 2021. The new single log-in, user account based system lets users conveniently make their own hours to fit their own and their counterparts plans. Video meetings are instantly scheduled and held in a secure environment. Time zone differences are considered automatically. Upon request, users are alerted by SMS of upcoming meetings, to mention a few of the online communication system’s new and practical features.
Owing to CoViD-19 conditions in Portugal, this Marketplace will be open for pre-arranged virtual (video) business meetings from 1st through 30th of March 2021. The new single log-in, user account based system lets users conveniently make their own hours to fit their own and their counterparts plans. Video meetings are instantly scheduled and held in a secure environment. Time zone differences are considered automatically. Upon request, users are alerted by SMS of upcoming meetings, to mention a few of the online communication system’s new and practical features.
In 2020, the outbreak of COVID-19 hit the world and brought great impact in various fields. In the post-epidemic era, 'danger' and 'opportunity' coexist, in which public medical service system and biomedical innovation have received unprecedented attention.
CHINA SHOWCASE ™ provides invaluable opportunities to expand your network with the most influential and experienced leaders in cross-border investment and business development transactions. Don't miss this opportunity to meet with leading industry investors and potential partners from China, US and EU. Through our partnership with EBD Group we are able to offer you this exclusive discount.
Presenting at Biotech Showcase allows companies to build their profile with investors and strategic partners. In addition, presenters can conduct one-to-one meetings and participate in informal networking. Hear the latest industry trends in workshops and panels featuring key biotech leaders, investors, pharma executives, and other industry advisors.
The euroPLX 74 Athens Marketplace for Pharma Business Opportunities takes pharma partnering to the next level: 60 days access to an online exchange of an abundance of business opportunities, including a two-days partnering event plus a subsequent four-weeks period for any number of pre-arranged follow-up or additional video meetings running on RauCon’s secure cloud environment. Attendees choose the in-person event + video meetings, or switch to video meetings only. Covid-19 conditions may require to switch the physical event to video mode.
euroPLX facilitated about 18,000 business negotiations in 2019 for almost 1,900 companies from 85 countries.
euroPLX facilitated about 18,000 business negotiations in 2019 for almost 1,900 companies from 85 countries.
Themed “Technological Innovations, Improving Healthcare”, ISPE Singapore Affiliate Conference and Exhibition 2020 brings you a three-days' virtual conference from 9 – 11 December 2020 that’s carefully curated to the relevance of the industry's needs.
With tracks focusing on key themes ranging from Industry-regulator collaboration, Innovations in digital pharma and to the recent COVID-19 market scenarios, attendees can expect the latest industry updates and insightful learning outcomes from high caliber international and regional speakers from regulators to pharma and subject matter experts.
To know more, visit www.ispesingapore.org
Lingmed team on behalf of Biotechgate cordially invites all life sciences and non-profit organizations to an online partnering event from November 23-26, 2020. Meeting requesting system will open soon and we expect to have over 1,500 delegates registered for the event incl. small Biotech and big Pharma companies. Lingmed's Biotechgate clients can participate this online partnering event with VIP complimentary pass. Please reach out to your support team or account managers.
China In The World: A program focused on what China must do to stand alongside the world’s leaders in the innovation ecosystem.
Six years ago, the first China Healthcare Summit asked how the nation would build the “Bridge to Innovation.” In 2020, we examine how China is now actually building the Bridge to Global Healthcare. A full two-day program highlighted by dialog among China-facing biotech innovators and their globally-facing Chinese counterparts.
Six years ago, the first China Healthcare Summit asked how the nation would build the “Bridge to Innovation.” In 2020, we examine how China is now actually building the Bridge to Global Healthcare. A full two-day program highlighted by dialog among China-facing biotech innovators and their globally-facing Chinese counterparts.
The 6th iteration of BDP Week will address the 2020 investment climate, technological advancements, industry case studies, and partnerships and expansion opportunities across key value chains. With improved networking windows and elevated exhibition platforms, join us as the industry convenes at this highly anticipated annual gathering of biopharma leaders.
The 26th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,350 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.
In 2020, the outbreak of COVID-19 hit the world and brought great impact in various fields. In the post-epidemic era, 'danger' and 'opportunity' coexist, in which public medical service system and biomedical innovation have received unprecedented attention.
A virtual gathering for the pharmaceutical industry The CPhI Festival of Pharma has been created to fill the gap left by in-person events at a time when travel and gatherings are off the cards.
The 10-day offering will bring the global pharma industry together, welcoming over 20,000 attendees and 700+ exhibitors, while offering you best-in-class networking, learning and sourcing opportunities – from the comfort of your home office.
The 10-day offering will bring the global pharma industry together, welcoming over 20,000 attendees and 700+ exhibitors, while offering you best-in-class networking, learning and sourcing opportunities – from the comfort of your home office.
China BioMed Innovation and Investment Conference (CBIIC), as an annual grand conference to promote the communication between pharmaceutical industry and investment industry, was established and initiated by China Pharmaceutical Innovation and Research Development Association (PhIRDA) in 2016. To promote the linkage between social capital and pharmaceutical innovation and improve the innovation capability of pharmaceutical industry, CBIIC focuses on China’s latest policies in pharmaceutical industry, explore the new trends of global pharmaceutical R&D and hot issues in investment and financing circle. CBIIC was built as an authorized, comprehensive, professional and international high level platform for the industry leaders, experts, scholars, domestic and foreign pharmaceutical innovation enterprises and investors to learn the trend of innovation and discuss new investment channels and innovative cooperation strategies.
Delivered digitally from 23 – 25 September 2020, the 7th Annual PharmaCon Asia co-locates 4 conferences featuring Clinical Trials, Regulatory Affairs, Market Access & Pricing, and Digital Pharma. Connect with global pharmaceutical leaders to discuss topics on digitalising consumer engagement, strategic pricing roadmap, regulations that will change the clinical trials landscape, and more.
BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. For this year’s digital event, BioPharm America will focus on Innovation and Investing, with the added collaboration of a number of diverse partners, whose unique offerings include live and recorded panel discussions, fireside chats, and company presentations from AI Applications for Drug Delivery and Development, LeadingBiotech Boston CEO & BD, Drug Delivery Partnerships, as well as the Xcelerate Startup Pitch Competition. The Collaboration Close-up forum will feature moderated discussion examining a specific collaboration, partnership or deal, with representatives from the two parties. Featured program elements will be available on demand, either live with Q&A (and also recorded) or prerecorded.
Lingmed team on behalf of Biotechgate cordially invites all life sciences and non-profit organizations to an online partnering event from Aug 31 - Sep 3, 2020. Meeting requesting system will open soon and we expect to have over 1,500 delegates registered for the event incl. small Biotech and big Pharma companies. Lingmed's Biotechgate clients can participate this online partnering event with VIP complimentary pass. Please reach out to your support team or account managers.
ChinaBio® Partnering Forum has grown to be the premier life science partnering conference in China since 2009. This year is our 12th anniversary, and for the first time will be delivered digitally! The conference will take place on August 25-27, using the powerful online platform provided by EBD Group, the largest provider of life science partnering events globally. Last year, there were over 1400 attendees from 25 countries who had over 3,200 1-1 meetings and saw nearly 80 company presentations during the 2-day conference. This year, going virtual will enable participants to hold meetings 24/7 using EBD Group's partneringONE® system, and to see the company presentations, keynote panels and workshops throughout the event. Join us this year for what will prove to be a dynamic and exciting event that will enable you to meet with colleagues from around the world, and to hear from executives, investors and industry experts from leading Chinese and global companies, as well as innovative startups.
Lingmed subscribers enjoy 20% discount using registration code ‘LM20’
Lingmed subscribers enjoy 20% discount using registration code ‘LM20’
The Largest Biotech Business Event in Asia!
Jointly organized by both the Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO). This year's event will be a unique blend of Online and Live gatherings, held on July 22-26 in Taipei, Taiwan with sessions streaming online. This event brings together biopharma executives and investors from Asia, North America, and Europe to meet and explore business opportunities with Taiwan’s emerging biotech sector in both Online and live settings. The five-day event will feature online company presentations, BIO One-on-One Partnering™, online seminars and workshops, and an online exhibition. It is a rare opportunity to reach out to Asia and Global Partners during the Pandemic! Conference agenda is now available at bioasiataiwan.com
The Asia Pharma Manufacturing Congress 2020 is one of the high-level strategic summits in the pharmaceutical industry in Asia. The top four global pharmaceutical markets are the United States, China, five European countries and Japan. Asia has an important status in the global pharmaceutical market and is growing rapidly. In recent years, the Chinese state has frequently issued policies on the pharmaceutical industry, vigorously reformed and pushed the policies into practice.
Being a pharmaceutical leader was once all about what you could sell. Marshalling your troops like a grand army, ready to fight for your share of voice. Today, we need a new kind of leadership – one that is authentic, all about data-driven decision-making, regulatory-grade real-world evidence, value-based access and empowering medical on the front line. To affect this change, 2000+ pharma-decision makers (from across Commercial, Sales, Marketing/Digital, IT, Medical, Patient Engagement, Market Access, RWE and Clinical) will join healthcare innovators on their yearly journey to the 18th eyeforpharma Barcelona Conference.
BIO-Europe Spring® is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups.
World Pharma Pricing Market Access & Evidence Congress 2020
March 18–19, 2020, Amsterdam, Netherlands
The World Pharma Pricing and Market Access Congress is Europe’s largest market access and pricing conference. Bringing together industry leaders from pharma companies, payers and HTAs, PPMA provides excellent opportunities to hear from patient led organisations, healthcare providers and other industry bodies. Join us in Amsterdam to discuss pricing, RWE, patient centricity and global market access all in one place.
BIO Asia International Conference is an exclusive partnering forum that brings together the global biotechnology and pharmaceutical industry with Japanese licensing and business development executives to explore licensing and investment deals.
The 10th Asia Pharma R&D Leaders Summit is one of the high-level strategic summits in the field of pharmaceutical R&D in Asia. This conference will gather together experts and senior executives from Chinese pharma companies, biotechnology companies, multinational pharmaceutical companies, research institutes and other companies, who are persisting in fighting for patients’ health on the front line of new drug R&D, discussing the status and trends of new drug R&D, exploring on strategy innovation and changes of drug development, clinical R&D and decision-making
Based on the transformation &upgrading and policy reform of China’s pharmaceutical industry, and theprevious successful experience of last session, China International Biopharma4.0 Summit(2020) will further deepen topics concerning the implementation of specific policies and regulations on the biological cell culture technology, protein characterization and optimization and ICH-Q series, and discuss more practical topics such as Pharma 4.0, the latest progress in technologies, future trends, digitization and intelligence of biopharma companies, CGMP quality management system from laboratories to plants, regulations on the use of SUS, optimization of cell culture technology, advanced experience of upstream and downstream biopharma technology, and outsourcing technology development IP.
Come and meet us during AgeingFit on January 28th and 29th, 2020 in Nice! AgeingFit is the leading Europen event dedicated to innovation in the Healthy Ageing sector. For its 4th edition, AgeingFit will gather healthy ageing companies, service providers, accommodation and care facilities, private and public research institutes, specialized associations and clusters, investors, health insurance providers, legislators and institutions… Their goal? Fostering business, research and financial partnerships with the objective to launch innovative products and services to the senior market.
Join this one-day program right before Biotech Showcase™. China Showcase provides invaluable opportunities to expand your network with the most influential and experienced leaders in cross-border investment and business development transactions. Don't miss this opportunity to meet with leading industry investors and potential partners from China, US and EU. Through our partnership with EBD Group we are able to offer you this exclusive discount.
Presenting at Biotech Showcase allows companies to build their profile with investors and strategic partners. In addition, presenters can conduct one-to-one meetings and participate in informal networking. Hear the latest industry trends in workshops and panels featuring key biotech leaders, investors, pharma executives, and other industry advisors.
"P4 China 2019 4th International Precision Medicine Convention " will be upgraded on the basis of rich experience successfully held in the past three years. More than 80 leading entrepreneurs, scientists and medical researchers will be invited to share multi-disciplinary research, analysis and mining of big biomedical data and application of artificial intelligence, early screening and early diagnosis of diseases, clinical individualized medication,precise drug development and real world research in five special forums,which will bring about an ideological collision between industry, university and research
TCome and join us at the 8th edition of BioFIT, on the 10th and 11th of December 2019 in Marseille, France! With the highest attending rate of TTOs, research institutes and academia together with big pharma, emerging and small biotech, diagnostics companies, pre-seed / seed / Series A investors, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.
How China’s healthcare pathfinders are leveraging the nation’s innovation, policy initiatives and access to capital markets in HK and domestic exchanges to build a globally facing industry. Six years ago, the first China Healthcare Summit asked how the nation would build the “Bridge to Innovation.” In 2019, we examine how China is now actually building the Bridge to Global Healthcare. A full two-day program highlighted by dialog among China-facing biotech innovators and their globally-facing Chinese counterparts.
The World Orphan Drug Congress and Cell & Gene Therapy is the meeting place for the rare disease community. The agenda covers the strategic and commercial aspects of bringing new treatments to patients who suffer from rare diseases. Government authorities, payers, industry and patient advocacy groups are all joining us. You can also meet biotech start-ups and investors who are showcasing their orphan drug technology and pipeline.
After a few years of tremendous growth and the creation of many new Chinese biotechs, 2019 is proving to be the year where they hone their strategies that will enable success for the long term. Industry dynamics have shifted: VC funding is much harder to come by, competition for development talent is fierce, and the field of companies vying for a share in hot new areas such as immuno-oncology/CAR-T is getting over-crowded. Where is the industry headed next and what are the implications for drug developers in China? Join 350+ senior-level clinical development executives from MNC and domestic biopharmas as they gather to discuss the next steps for the industry.
BIO-Europe® 2019 - 25th Annual International Partnering Conference
November 11–13, 2019, Hamburg, Germany
The 25th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,350 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.
Come and join us and the other 600 international participants at the 6th edition of NutrEvent, on October 22nd & 23rd, 2019 in Rennes, France! NutrEvent is the leading European partnering event dedicated to innovation in Food, Feed, Nutrition and Health. It aims at identifying industrial, scientific, commercial and financial partners for your innovation projects. NutrEvent gathers 600+ international actors: ingredient suppliers and distributors, finished food product and food supplement industries, academic institutions, technology transfer organisations, research institutes, R&D services and consulting firms and investors.
Bio Partnering APAC 2019 is the most powerful way to make big deals in bio pharma industry in Asia Pacific Region. Against the background of increasing government policy support, exciting biotechnology breakthroughs and growing venture capital investment, themed on “R&D Strategy Innovation under New Regulatory Policy, Collaboration Opportunity under New Global Situation”.
To promote the capitalization and industrialization of pharmaceutical innovative achievements, encourage more investment to Chinese pharmaceutical innovation industry, facilitate the timely transformation of unmet clinical needs, China Pharmaceutical Innovation and Research Development Association (PhIRDA) will host the 2019 China BioMed Innovation and Investment Conference (2018 CBIIC) in Suzhou Industrial Park on September 21-23, 2019. The theme of 2019 CBIIC is "Promote the linkage between social capital and pharmaceutical innovation, improve innovation capability of pharmaceutical industry".
BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Life science executives from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®.
With a record 1000+ participants, the ISPE Singapore Conference and Exhibition broke new ground in 2018. We saw a strong presence of Pharma and Manufacturers, supported in equal measure my Regulators, EPCM, and various other stakeholders and service providers. Focused and insightful learning outcomes alongside the many networking opportunities created an undeniable buzz amongst all participants, and PharmaNite in particular was a roaring success. The ISPE Singapore affiliate would like to thank industry for its support, and endorsement of the fact that this high quality conference and exhibition is now the preeminent gathering for industry in ASEAN
Co-organized by the global Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO), the inaugural BIO Asia-Taiwan 2019 Conference and Exhibition will be held in Taipei, Taiwan 24-28 July, 2019. A week-long festival of biotech-themed conferences, meetings, and presentations, BIO Asia-Taiwan is poised to become Asia’s most important gathering of the biotechnology community. Join 1,500 participants from 25 countries at the three-day conference for sessions on AI for healthcare, advances in precision medicine, cell and gene therapies, M&A in the healthcare sector, and more.
Held on the 25th and 26th of June 2019 in Lille – France, and gathering 700 international participants from over 25 countries, MedFIT is the leading European business convention dedicated to innovation partnerships in the fields of medical technology, diagnostics and digital health sector. MedFIT is the place-to-be to identify innovative products and technologies, to build R&D, find licensing opportunities and financial partnerships. MedFIT brings together industry leaders, innovative MedTechs, diagnostics start-ups, TTOs, academic institutions, R&D services as well as companies and investors to help facilitate market access for innovations.
The 7th Vaccine China Leaders Annual Meeting 2019 is one of the most top Strategic Vaccine Summits in China and even Asian region, which annually focuses on the Innovative Development and Strategic Partnership of the Whole Vaccine Industry Chain. Themed on “Innovation, Cooperation, Efficiency, Safety”, by two separate Human /Animal Vaccine Forums, the VacChina 2019 will invite the Leading Executives and Decision Makers from the global Vaccine R&D and Manufacturers, Biotech Companies, Academic Institutes, Governmental and Public Health
With demonstrated success year on year, IBC’s BioPharma Development and Production Week in China enjoys unparalleled industry support. Known for generating knowledge, creating business opportunities, and bringing innovative ideas to the table, the BDP Week is now more impactful than ever with 5 high level conferences, learning seminars, focused trade show and business matching to boot. 400+ participants will get to hear from over 100 local and global experts, and reap the benefit of a unique business matching opportunity. Regulation, growth trends, digitalisation, technology innovation and partnering will form the bedrock of the 5 co located conferences.
The future of biomanufacturing is set for a revolution. New outsourcing trends, mass customisaton and precision medicine, intensification versus continuous models, and the rise of intelligent facilities, are but some of the issues driving the change. Smart biomanufacturing is increasingly playing a crucial role in fulfilling the needs of the market
China steadfastly continues to work regulations on biosimilars to help make the market easier to breakthrough, and the recent Priority Review legislation is a case in point. As the industry continues to evaluate cost, risk and incentives for Biosimilar development, new developments to promote R&D and adjustments to approval pathways are designed to help manufacturing and commercialization of biosimilars
The cell therapy market is exploding with opportunities, and the total market volume for CAR-T therapy alone is expected to reach USD 1 trillion by 2030. China boasts more cell therapy trials than the US, and it is increasingly leveraging its strategic advantage in context to labour costs, precision manufacturing, and now also a more accommodating regulatory regime for this sector
Recent regulatory developments have invigorated China’s clinical trials industry. Greater flexibility to encourage innovation, the 60 day CDE timeline for Phase 3 trials, site accreditation process revamp, acceptance of foreign data towards new drug applications, are just some of the measures expected to generate renewed enthusiasm amongst foreign and local sponsors
The global market size for cell line development is expected to exceed USD 7.5 billion by 2024. Some key market drivers include the demand for cell therapies, growing oncology market, increasing demand for vaccines and monoclonal antibodies, and continued growth in the vaccine market
ChinaBio® Partnering Forum is the premier life science partnering event in China since 2009. Our 11th annual conference will be held on May 8–9, 2019 in Shanghai, China. The event will attract over 1,400 biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering. ChinaBio® Partnering Forum 2018 had more than 1,200 delegates from over 500 companies and 25 countries, over 2,500 one to one meetings, 80 company presentations, 900+ licensing opportunities , and 70% of the attendees from China, making it the largest international partnering conference in China
The 11th Annual China Healthcare Investment Conference (CHIC) will highlight the latest healthcare investment opportunities in light of China's recent major policy reforms aimed to bring domestic innovation to the global stage. As always, CHIC features perspectives from leading venture capital, private equity, and public equity investors as well as prominent Chinese and international healthcare companies
BIO-Europe Spring® is the springtime counterpart to EBD Group's flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group's sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups
Deep integration of next-generation ICT technologies and manufacturing industry is driving a round of industrial transformation, creating new manufacturing methodologies, industrial forms, business modes and economic growth. All countries are encouraging innovation in science and technology. Following Germany's Industry 4.0 announcement, China released Made in China 2025, a national strategy to accelerate the transformation and upgrading of manufacturing industry which is led by smart equipment, smart factory and smart manufacturing based on cyber-physical System (CPS)
The 16th annual BIO Asia International Conference is an exclusive partnering forum that brings together the global biotechnology and pharmaceutical industry to explore licensing collaborations and investor engagement in the current Asia-Pacific business and policy environments. Gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market
Asia Pharma R&D Leaders 2019 is designed to be a premium strategic platform for big pharmas, biotechs, academia and other stake holders in pharma industry to meet, communicate and establish partnership on pharma R&D. Leading executives will discuss key topics of global R&D trends, development strategies, innovation capability building and collaboration opportunities
Biotech Showcase™ is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world
Join this one-day program right before Biotech Showcase™. China Showcase provides invaluable opportunities to expand your network with the most influential and experienced leaders in cross-border investment and business development transactions. Don't miss this opportunity to meet with leading industry investors and potential partners from China, US and EU. Through our partnership with EBD Group we are able to offer you this exclusive discount. Save USD 200 when you register with Lingmed discount code LM200CS19
PHARMCHINA is a long-established trade fair for pharmaceutical preparations, health products and related technologies and services in China. As a platform for domestic pharmaceutical preparations, health products and related technologies, such as service trade, information exchange platform and cooperation docking and learning, the PHARMCHINA advocates the concept of “medical science and technology to create a healthy future” and promotes the Chinese pharmaceutical industry together with the whole industry to an innovation-driven, endogenous growth, and expansion of the overall sustainable development path
2018 International Life Health Industry (Shanghai) Exhibition & Summit Forum
November 23-25, 2018, Shanghai, China
2018 International Life Health Industry (Shanghai) Exhibition & Summit Forum ( “Life Health EXPO” in short) kept its subject of “ Life enlivens today, health serves tomorrow” in Shanghai Private Health Management EXPO. By sectors, it displays the platform for the entire industrial chain of Life Science, Biotechnology, Research & Development, Manufacturing and Applications, with exhibition areas of Life & Big Health, Life Science Simulation, Innovative Biotechnology, Life Industrial Park and other exhibition areas
Five years ago, the first China Healthcare Summit asked how the nation would build the “Bridge to Innovation.” In 2018, we examine how China is now actually building the Bridge to Global Healthcare. A full two-day program highlighted by dialog among China-facing biotech innovators and their globally-facing Chinese counterparts. The China Summit is a VIP-only event for busy biopharma and life sciences executives and investors to get a first-hand look at the innovation, business and policy transformations taking place in China. The conference is THE place to meet the right Chinese investors and partners in an intimate setting
The 24th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,000 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners
Biopharma Development & Production Asia-Pacific
November 1-2, 2018, Singapore, One Farrer Hotel & Spa
The annual Biopharma Development & Production (BDP) Asia Pacific returns with a refreshed agenda across 3 co-located conferences, spanning Bioprocess and Technology, Biotech Investment, as well as Biopharma Supply Chain Management.
With the increased adoption of innovative technology and investments in advanced R&D, coupled with higher manufacturing output, these are shaping to be the key drivers of the industry in the next few years. Hear from 40+ global and regional experts as they share exclusive insights at market-facing sessions and panel discussions
With the increased adoption of innovative technology and investments in advanced R&D, coupled with higher manufacturing output, these are shaping to be the key drivers of the industry in the next few years. Hear from 40+ global and regional experts as they share exclusive insights at market-facing sessions and panel discussions
Phamacon organizing committee will provide the most top-level conference platform for Chinese chemical enterprises, and promote the exchange and progress of the whole industry. The summit will gather more than 500 domestic and foreign leading chemical companies and leaders of drug regulatory agencies to explore common difficulties and challenges faced by domestic and foreign pharmaceutical enterprises, such as policies and regulations, R & D technology and development trends. Looking forward to welcoming you in Pharmacon 2018!
Best Media is pleased to announce the launch of the 8th Annual Drug Delivery and Formulation Asia Summit at Wyndham Bund East Shanghai Hotel in China on Oct.25 & 26, 2018. This summit provides drug delivery and specialty pharmas with a platform to present their technologies and get the latest insights on what the delivery and formulation needs are. And presents a strategic level program for pharma and business development professionals with a thorough overview of the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug
The 13rd BD Forum will be held in Ningbo on October 24-26. The forum aims to explore how pharmaceutical and medical companies can expand their business and investment opportunities in the face of global changes, promote rapid growth in integration, and achieve “embrace globally and achieve value”
A multi-professional platform for oncology education and exchange, and for immense international visibility for scientific research, this year the Congress also features a dedicated nursing track through a collaboration with the European Oncology Nursing Society (EONS)
Lingmed sincerely invite you to this insights sharing and strategic discussions on what has happened and is happening to the China life sciences market. Please join us on 19 September at Webex to exchange your views and make yourself ready for the rapidly changing market
BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Life science executives from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®, the world's leading web-based partnering system. BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®
BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Life science executives from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®, the world’s leading web-based partnering system. BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®.
The Antibody and Antibody-based Therapeutics have entered the center stage of drug discovery. Roughly, as of end of 2017, over 70 antibody therapeutics have been approved. Not only in Western Countries, there have been also considerable Biologics R&D, manufacturing and commercial activities in China/Asia. In 2015, the China FDA also received the country's first biosimilar guidelines to establish the basic principles for development and technical evaluation of biosimilars towards the adoption of a more concrete and well-defined regulatory pathway. In return, the 2018 Antibody-based Therapeutics and BioProduction Forum is to build up and facilitate the communication and partnerships to accelerate Biologics R&D, Characterization and Production
Organised by the Singapore affiliate of the International Society for Pharmaceutical Engineering (ISPE), this annual meeting is open to all pharma and bio manufacturing Professionals. Building on the theme “Innovating for Next Generation Pharma Manufacturing”, it is the must-attend industry event which highlights best practices, technology and services from manufacturing facility design to finished product. In 2017, the event attracted 800+ participants and visitors from 26 countries and has established itself as a pre-eminent platform for Pharma, CMOs, Vaccine companies, Medical Device manufacturers, Researchers, Engineering and EPCM, Academia and wider service providers
BioTaiwan, one of the largest biotech gatherings in Asia features 3-day BioBusiness Asia Conference (BBA) focusing on precision medicine, innovative investment, advanced technologies, Greater China and ASEAN Opportunities with Company Presentation, One-on-one Partnering, and 4-day Exhibition. In 2017, 1,000+ delegates from 20+ countries attended BBA with 1300 booths from 600+ exhibitors. Join us at BioTaiwan 2018 to network with top executives, catch up with the latest technologies, and find business opportunities abundant in Taiwan, one of the most under-explored biotech locations
The research and development of new drugs ensure that we can obtain the leading strategic position in technological and economic competition throughout the world. The innovation strategy and R&D model are the cores of the development of pharmaceutical companies. China's entry into ICH marks the beginning of new drug development into the New Era of globalization. In the past three years, government departments have established a sustainable environment for innovation in the pharmaceutical industry from the dimensions of policy orientation, technical support, human resources, and capital input.
Facing the needs of project progress management, risk response, supplier selection, and innovation and feedback from clinical trial centers in the process of clinical projects, the BCD2018 (2nd) Biopharmaceutics Clinical Development Summit to be held in CBI will focus on clinical Operational drills, case sharing and other fields in operation. The conference will focus on the exchange of training for the implementation of specific clinical programs after the drug approval IND. It will also provide in-depth exploration of the progress control, risk control, quality control, and other aspects of the clinical program. I hope this meeting will provide a platform for more exchanges, learning and progress for more clinical practitioners
Since our founding in 1964, DIA has provided a global stage for collaboration to address healthcare challenges. As a memberdriven volunteer organization, professionals from 80 countries have engaged with DIA through our unparalleled membership network, educational offerings, and professional development opportunities. Everyone passionate about working at the global intersection of science, healthcare, and regulation come together at DIA. In a uniquely neutra
Shanghai International Forum on Biotechnology & Pharmaceutical Industry (Bio-Forum) has evolved into an influential international conference in the area of biotechnology and pharmaceutical industry. This year, Bio-Forum will be held at Shanghai International Convention Center on May 23-25, 2018. Nearly 100 well-known experts, scholars, entrepreneurs and government officials from home and abroad will be invited to give excellent speech and about 600 delegates will attend the forum. The forum consists of the following parts: Keynote Speech, Parallel Sessions, Partnering, and Exhibition. We are looking forward to meeting you in Shanghai
2018 Shandong Pharmaceutical Industry Development Summit Forum, Sponsored by Shandong Pharmaceutical Industry Association, in order to boost scientific and technological progress in Shandong pharmaceutical industry and improve the independent innovation capability of pharmaceutical companies. Today, it has become an indispensable and important partner for the development of the pharmaceutical industry. Provide assistance and enlightenment on important aspects such as development ideas and solutions to industrial development problems. To bring more practical promotion and opportunities for the development of more industry enterprises. The conference will be held in Jinan, Shandong Province from May 17th to 18th. Welcome your active participation
With 350+ participants representing the core of China’s market, the Biopharma Development & Production Week is back to spur industry learning, showcase innovation and enable business contacts. With 3 co located conferences, 70+ speakers and over 60 technical and commercial sessions, this is without doubt the only forum with demonstrated value add for participants. Against the bedrock of emerging and disruptive technologies, new generation facilities and continuous process improvement, participants will get quality practical information that enables them to develop advance capabilities in developing and manufacturing cell lines, biosimilars, biobetters, antibodies, vaccines and novel biologics
ChinaBio® Partnering Forum has grown to be the premier life science partnering conference in China since 2007. This year, it is our 10th anniversary! The conference will take place on April 24-26 in Suzhou, an emerging hub of life science in Eastern China. Suzhou is committing significant funding and resources to the life science industry, including building the Bio industry, with 204,000 ㎡ of incubator, and manufacturing facilities. ChinaBio® Partnering Forum features EBD Group's partneringONE® system, enabling delegates to efficiently arrange 1-1 meetings with companies from across the life science value chain. Join us at ChinaBio® Partnering Forum 2018, to meet over 1,000 of biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering in Suzhou
LINGMED LIMITED SHANGHAI together with Venture Valuation is pleased to invite you to a full-day workshop on pharma – biotech Product and Company Valuation
• Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world
• Know how to assess and calculate the value of a biotech company
• Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal
• Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world
• Know how to assess and calculate the value of a biotech company
• Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal
Taihu (Mashan) Life science and Healthcare Forum - 2018 Biopharmaceutical and Financial Innovation
April 20-22, 2018, Wuxi, China
In order to further promote the reform and development of biopharmaceutical in China and encourage international exchanges and cooperation to discuss Chinese biopharmaceutical industry development plan, the "Taihu (Mashan) Life science and Healthcare Forum - 2018 Biopharmaceutical and Financial Innovation" will be held in Wuxi in April 20-22, 2018. The theme of the conference is "Biopharmaceutical Innovation and Capital Financing". We will invite top experts, scholars, and industry professionals from global biopharmaceutical research and development innovation and financial fields to discuss clinical oncology, protein antibody research, capital financing for biopharmaceutical innovation, new drug delivery systems, research and evaluation of new vaccines topics, etc
To speed up Asian Bioinnovatives and Biosimilars development and to promote industry exchange and cooperation, BioCon China 2018, as the largest and the most professional annual meeting, has 2 streams of forum: 5th World-China Biosimilars Forum and 4th International Symposium on Biopharmaceutical Innovation and Development.
BioCon China 2018 (April 20-21, Shanghai) will assemble 40+ global and China's regulators, tech executives and expert scientists from leading biopharmas, and 500+ p
BioCon China 2018 (April 20-21, Shanghai) will assemble 40+ global and China's regulators, tech executives and expert scientists from leading biopharmas, and 500+ p